October 5, 2020 by Chain Drug Review
ACA, Affordable Care Act, Supreme Court
News, October 5, 2020

NEW YORK — Ever since it was signed into the law by President Obama on March 23, 2010, the Affordable Care Act has been under constant attack by Republicans seeking to undermine the former president’s signature legislation. Despite surviving numerous attempts by congressional Republicans to repeal it and its constitutionality being upheld by a majority-conservative
October 5, 2020 by Guy Yehiav
data & analytics, fraud
October 5, 2020, Technology

U.S. retailers lost a combined $61.7 billion to the various components of total retail loss (shrink) in 2019, an $11 billion increase from the previous year that reflected 1.62% of all sales. In this article we will focus on internal theft — a large component of the overall 42 categories of total retail loss. The
October 5, 2020 by Jeffrey Woldt
COVID-19
October 5, 2020, Opinion

The Trump administration’s fitful response to COVID-19 has failed to meet the moment, one in which a pandemic the likes of which has not been seen in a century threatens the well-being and livelihood of millions of Americans. As this issue of Chain Drug Review was about to go to press, more than 6.9 million
October 5, 2020 by David Pinto
Alex Gourlay, John Standley, Stefano Pessina, Walgreens
October 5, 2020, Opinion

Amid the coronavirus pandemic that never seems to end, several stories have captured the attention of those who follow the chain drug community. As of this writing, none is as compelling as the drama at Walgreens, where an ongoing shuffle at the very top levels of management has raised issues and questions for which there
October 5, 2020 by Chain Drug Review
BOPIS, COVID-19
October 5, 2020, Opinion

NEW YORK — According to a new report from Incisiv — “The New Store Shopper in High-Touch Retail” — commissioned by Manhattan Associates, digital is now the front door to the store. COVID-19, the report concludes, has brought radical change to the retail industry, not least a reprioritization of the store experience for pandemic-era shoppers.